Ghent University Hospital
🇧🇪Belgium
Pharmacokinetics of Ciprofloxacin in Pediatric Patients
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 22
- Registration Number
- NCT02598362
- Locations
- 🇧🇪
Universitair Ziekenhuis Brussel, Brussel, Belgium
🇧🇪Ghent University Hospital, Ghent, Belgium
Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer
Phase 2
Completed
- Conditions
- Ovarian CancerPrimary Peritoneal Cancer
- Interventions
- Procedure: Cytoreductive surgeryDrug: IPEC with Cisplatin (75mg/m²)Drug: IPEC with Cisplatin (100mg/m²)Drug: Hypertherm IntraPEritoneal Chemotherapy with Cisplatin (75mg/m²)Drug: HIPEC with Cisplatin (100mg/m²)
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 56
- Registration Number
- NCT02567253
- Locations
- 🇧🇪
UZ Ghent, Ghent, East-Flanders, Belgium
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy
Not Applicable
Terminated
- Conditions
- Epilepsia Partialis ContinuaStatus Epilepticus
- Interventions
- Procedure: repetitive transcranial magnetic stimulation
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 4
- Registration Number
- NCT02560597
- Locations
- 🇧🇪
University Hospital, Ghent, Ghent, Belgium
Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses
Phase 4
Completed
- Conditions
- Prevention of Infections With Bordetella Pertussis
- Interventions
- Biological: BoostrixBiological: Placebo (Saline)
- First Posted Date
- 2015-09-21
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 240
- Registration Number
- NCT02555540
- Locations
- 🇧🇪
Center for Vaccinology, Ghent, East-Flanders, Belgium
Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses
Phase 4
Completed
- Conditions
- Safety Markers of Adjuvanted Influenza Vaccine
- Interventions
- Biological: SalineBiological: Fluad
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 240
- Registration Number
- NCT02523287
- Locations
- 🇧🇪
Center for Vaccinology, Ghent, East-Flanders, Belgium
Antibiotic Dosing in Pediatric Intensive Care
Recruiting
- Conditions
- PharmacokineticsAmoxicillin-clavulanateVancomycinTeicoplaninMeropenemCiprofloxacinAmikacinPiperacillin-tazobactam
- Interventions
- Procedure: blood sampling in patients receiving teicoplanin as part of routine clinical care.Procedure: blood sampling in patients receiving amikacin as part of routine clinical care.Procedure: blood sampling in patients receiving vancomycin as part of routine clinical care.Procedure: blood sampling in patients receiving meropenem as part of routine clinical care.Procedure: blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical careProcedure: blood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.Procedure: blood sampling and urine smapling in patients receiving ciprofloxacin as part of routine clinical care.
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 640
- Registration Number
- NCT02456974
- Locations
- 🇧🇪
Ghent University Hospital, Hospital Pharmacy, Ghent, Belgium
Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients
Early Phase 1
Withdrawn
- Conditions
- ImmunologyRadiotherapy
- Interventions
- Radiation: Stereotactic body radiotherapy
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- University Hospital, Ghent
- Registration Number
- NCT02441270
- Locations
- 🇧🇪
University Hospital - Radiotherapy Department, Ghent, Belgium
EEG@HOME (Phase 3b of the Project, Interviews)
Not Applicable
Terminated
- Conditions
- Epilepsy
- Interventions
- Other: Interview about prototype EEG-cap
- First Posted Date
- 2015-04-28
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 1
- Registration Number
- NCT02428348
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Belgium
Influence of Non-invasive Neurostimulation (Transcutaneous Vagus Nerve Stimulation) on 1. the Noradrenergic Release in the Brain and 2. a Neuropsychological Memory Task
Not Applicable
Completed
- Conditions
- Cognitive DeclineEpilepsy
- Interventions
- Device: Sham stimulation (Nemos®, Cerbomed GmbH)Device: Transcutaneous vagus nerve stimulation (Nemos®, Cerbomed GmbH)
- First Posted Date
- 2015-04-06
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 44
- Registration Number
- NCT02409069
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Belgium
EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers)
Not Applicable
Completed
- Conditions
- Epilepsy
- Interventions
- Device: EEG
- First Posted Date
- 2015-04-03
- Last Posted Date
- 2017-11-28
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 4
- Registration Number
- NCT02408653
- Locations
- 🇧🇪
University Hospital, Ghent, Ghent, Belgium
© Copyright 2025. All Rights Reserved by MedPath